Lyophilized Injectable Market delivers a comprehensive study of the market, including its dynamics, structure, characteristics, key players, growth and demand drivers, etc. As a complete analysis report, it covers all details inside analysis and outlook according to the insight partners
An exclusive Lyophilized Injectable Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.
Single-Use Vials, by Type of Packaging, to Account for Largest Share in Lyophilized Injectable Market During 2022–2028. Increasing use of single-use vials owing to various advantages such as ease in self administration and reduction in medical waste along with the increase in home healthcare and self-administration of drugs is expected to generate demand for single use vials packaging and contribute the market growth over the forecast period.
According to our latest study on “Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Packaging, Type of Delivery, Indication, and End User,” the market is expected to grow from US$ 2,719.42 million in 2021 to US$ 4,001.27 million by 2028; it is expected to grow at a CAGR of 5.8% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
The prominent/emerging players in the Lyophilized Injectable Market research include:
- Curia Global, Inc.
- Recipharm AB
- Vetter Pharma
- Jubilant HollisterStier LLC (Jubilant Pharma Limited)
- Aristopharma Ltd.
- CordenPharma International
- Credence MedSystems, Inc.
- G. Biopharm Pvt. Ltd.
Based on type of packaging, the global lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment is likely to account for the largest market share during 2022–2028. By type of delivery, the market is segmented into prefilled diluent syringes, single-step devices, proprietary reconstitution devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is likely to continue its dominance during the forecast period. Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment is likely to account for the largest market share during 2022–2028. By end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021 and is likely to continue its dominance during the forecast period.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi